207 related articles for article (PubMed ID: 8137105)
21. D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with 123I-iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment.
Schröder J; Silvestri S; Bubeck B; Karr M; Demisch S; Scherrer S; Geider FJ; Sauer H
Biol Psychiatry; 1998 May; 43(9):660-5. PubMed ID: 9582999
[TBL] [Abstract][Full Text] [Related]
22. Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia.
Lavalaye J; Linszen DH; Booij J; Reneman L; Gersons BP; van Royen EA
Psychiatry Res; 1999 Nov; 92(1):33-44. PubMed ID: 10688158
[TBL] [Abstract][Full Text] [Related]
23. Dopamine D2-receptors in human narcolepsy: a SPECT study with 123I-IBZM.
Hublin C; Launes J; Nikkinen P; Partinen M
Acta Neurol Scand; 1994 Sep; 90(3):186-9. PubMed ID: 7847059
[TBL] [Abstract][Full Text] [Related]
24. [99mTc]TRODAT-1/[123I]IBZM SPECT studies of the dopaminergic system in Tourette syndrome.
Hwang WJ; Yao WJ; Fu YK; Yang AS
Psychiatry Res; 2008 Feb; 162(2):159-66. PubMed ID: 18248965
[TBL] [Abstract][Full Text] [Related]
25. Prolactin plasma levels and D2-dopamine receptor occupancy measured with IBZM-SPECT.
Schlegel S; Schlösser R; Hiemke C; Nickel O; Bockisch A; Hahn K
Psychopharmacology (Berl); 1996 Apr; 124(3):285-7. PubMed ID: 8740053
[TBL] [Abstract][Full Text] [Related]
26. Effect of haloperidol dose on iodine-123-IBZM brain SPECT imaging in schizophrenic patients.
Vallabhajosula S; Hirschowitz J; Machac J
J Nucl Med; 1997 Feb; 38(2):203-7. PubMed ID: 9025736
[TBL] [Abstract][Full Text] [Related]
27. Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.
Hierholzer J; Cordes M; Venz S; Schelosky L; Harisch C; Richter W; Keske U; Hosten N; Mäurer J; Poewe W; Felix R
J Nucl Med; 1998 Jun; 39(6):954-60. PubMed ID: 9627325
[TBL] [Abstract][Full Text] [Related]
28. [123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects.
Schlösser R; Schlegel S; Hiemke C; Nickel O; Bockisch A; Rao ML; Hahn K
Psychiatry Res; 1997 Sep; 75(2):103-14. PubMed ID: 9351492
[TBL] [Abstract][Full Text] [Related]
29. Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine.
Schmitt GJ; Meisenzahl EM; Dresel S; Tatsch K; Rossmüller B; Frodl T; Preuss UW; Hahn K; Möller HJ
J Psychopharmacol; 2002 Sep; 16(3):200-6. PubMed ID: 12236625
[TBL] [Abstract][Full Text] [Related]
30. Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis.
Hierholzer J; Cordes M; Schelosky L; Richter W; Keske U; Venz S; Semmler W; Poewe W; Felix R
J Nucl Med; 1994 Dec; 35(12):1921-7. PubMed ID: 7989970
[TBL] [Abstract][Full Text] [Related]
31. Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications.
Frankle WG; Gil R; Hackett E; Mawlawi O; Zea-Ponce Y; Zhu Z; Kochan LD; Cangiano C; Slifstein M; Gorman JM; Laruelle M; Abi-Dargham A
Psychopharmacology (Berl); 2004 Oct; 175(4):473-80. PubMed ID: 15083259
[TBL] [Abstract][Full Text] [Related]
32. Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM-SPECT in a Wilson's disease patient with generalized dystonia.
Schwarz J; Tatsch K; Vogl T; Kirsch CM; Trenkwalder C; Arnold G; Gasser T; Oertel WH
Mov Disord; 1992; 7(1):58-61. PubMed ID: 1532631
[TBL] [Abstract][Full Text] [Related]
33. Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome.
Jauss M; Krack P; Franz M; Klett R; Bauer R; Gallhofer B; Dorndorf W
Mov Disord; 1996 Nov; 11(6):726-8. PubMed ID: 8914102
[TBL] [Abstract][Full Text] [Related]
34. Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796.
Seibyl JP; Zea-Ponce Y; Brenner L; Baldwin RM; Krystal JH; Offord SJ; Mochoviak S; Charney DS; Hoffer PB; Innis RB
J Nucl Med; 1996 Jan; 37(1):11-5. PubMed ID: 8543979
[TBL] [Abstract][Full Text] [Related]
35. Correlation between fine motor activity and striatal dopamine D2 receptor density in patients with schizophrenia and healthy controls.
Yang YK; Chiu NT; Chen CC; Chen M; Yeh TL; Lee IH
Psychiatry Res; 2003 Jul; 123(3):191-7. PubMed ID: 12928107
[TBL] [Abstract][Full Text] [Related]
36. Lateralized differences in iodine-123-IBZM uptake in the basal ganglia in asymmetric Parkinson's disease.
Knable MB; Jones DW; Coppola R; Hyde TM; Lee KS; Gorey J; Weinberger DR
J Nucl Med; 1995 Jul; 36(7):1216-25. PubMed ID: 7790947
[TBL] [Abstract][Full Text] [Related]
37. Striatal D2 receptor binding in sleep bruxism: a controlled study with iodine-123-iodobenzamide and single-photon-emission computed tomography.
Lobbezoo F; Soucy JP; Montplaisir JY; Lavigne GJ
J Dent Res; 1996 Oct; 75(10):1804-10. PubMed ID: 8955676
[TBL] [Abstract][Full Text] [Related]
38. Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone.
Busatto GF; Pilowsky LS; Ell PJ; Costa DC; Verhoeff NP; Kerwin RW
Br J Psychiatry; 1993 Dec; 163():833-4. PubMed ID: 7508329
[No Abstract] [Full Text] [Related]
39. Dopaminergic neurotransmission in patients with schizophrenia in relation to positive and negative symptoms.
Pogarell O; Koch W; Karch S; Dehning S; Müller N; Tatsch K; Poepperl G; Möller HJ
Pharmacopsychiatry; 2012 May; 45 Suppl 1():S36-41. PubMed ID: 22565233
[TBL] [Abstract][Full Text] [Related]
40. Decrease of D2 receptors indicated by 123I-iodobenzamide single-photon emission computed tomography relates to neurological deficit in treated Wilson's disease.
Oertel WH; Tatsch K; Schwarz J; Kraft E; Trenkwalder C; Scherer J; Weinzierl M; Vogl T; Kirsch CM
Ann Neurol; 1992 Dec; 32(6):743-8. PubMed ID: 1471864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
